The results showed that ZFP36L2 was significantly positively correlated with the three immune scores and multiple types of immune cells, while immune cells had been demonstrated being significantly related to the progression of glioma in previous studies (Patel et al., 2014; Wang et al., 2018). Here, ZFP36L2 is linked to central nervous system cancer.